Case 3: A 39-Year-Old Female With Conjunctival Redness and Swelling
This program is sponsored by Santen.
Case 2: A 59-Year-Old Male With Lid Erythema and toothpaste like secretions
Case 1: A 41-Year-Old Female With Eye Redness
A 38-Year-Old Male With Chronic Light Sensitivity
A 28-Year-Old Male With Burning and Blurred Vision
Dr. Chang: What I wish I knew before entering optometry
Clark Chang, OD, MSA, MSc, FAAO, shares why he wish he'd known more about the versatility of the optometric field before starting out in the optometric field.
Tech advancements in eyecare ft. Mile Brujic, OD, FAAO
Mile Brujic, OD, FAAO, speaks on why he views diagnostics and pharmaceuticals as the best technological advancements in eyecare.
Advancements in tech: OCT
Jessica Steen, OD, FAAO, shares why she views the development of OCT-angiography as her personal favorite technological advancement in eyecare.
A new age for treating presbyopia?
Marc R. Bloomenstein OD, FAAO, and Mile Brujic, OD, FAAO, share the key takeaways from their presentations at EyeCon ’21.
Visions of the future: Contact lenses of today and tomorrow
Two EyeCon ’21 faculty panelists highlight their presentation, “Visions of the Future: Contact Lenses of Today and Tomorrow.”
Dr. McDonnell shares how AAO experience can help ophthalmologists reset for 2022
Peter J. McDonnell, MD, reflects on key takeaways from AAO 2021
Alex Nixon, OD, MS, FAAO presents J&J Vision findings from new myopia research at AAO
New research explores visual symptoms and their impact in children wearing soft contact lenses for myopia control
Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients
Podcast: Mark Dunbar, OD, FAAO dives into glaucoma, part 2
A Future for Remote Monitoring Centers in Eye Disease
Enthusiasm regarding the acceleration of technology advances, including retinal monitoring centers, that can be used to help prevent disease progression for patients with eye diseases.
Reimbursements for Remote Monitoring in Dry AMD
Considerations for using remote monitoring and navigating through the reimbursement process when caring for patients with dry age-related macular degeneration.
Dr. McDonnell shares advice for first-time attendees on how to enjoy AAO 2021 to the fullest
Peter J. McDonnell, MD, shares what to expect at AAO 2021
Podcast: Mark Dunbar, OD, FAAO dives into glaucoma, part 1
Dry AMD: Billing Updates for Remote Monitoring Centers
What optometrists should know about the American Medical Association’s establishment of 3 new CPT Category III codes to report patient-initiated remote retinal optical coherence tomography scans.
Integrating Retinal Monitoring Centers Into Clinical Workflows
Considerations for more widespread use of retinal monitoring centers based on clinician and patient feedback.
The next frontier of presbyopia treatments
As the number of presbyopia patients continues to grow, so do their visual demands.
How to manage early cataract surgery complications
Review treatment options for both early and late complications of cataract surgery.
Ocular findings of COVID-19
COVID-19 affects every part of the eye, front to back.
The optometrist’s role in diagnosing and treating hypertension
ODs have the rare opportunity to engage as well as educate patients on hypertension.
Eye injuries outside the workplace: the OD's important role and legal responsibilities
The important role of the optometrist and legal responsibilities
How to utilize motivational interviewing in patient communications
Communication styles to adapt to an optometric setting
Is cultural competency a necessary optometric skill?
Why ODs should consider their own culture and how it influences interactions with patients.
Managing AMD: Evaluating Remote Monitoring Center Data
The types of data provided by retinal monitoring centers and how to best utilize information provided to better treat patients who have dry age-related macular degeneration.